Estrogen replacement therapy II: a prospective study in the relationship to carcinoma and cardiovascular and metabolic problems
about
Hormone therapy for preventing cardiovascular disease in post-menopausal womenHormone therapy in postmenopausal women and risk of endometrial hyperplasiaLong term hormone therapy for perimenopausal and postmenopausal womenHormone therapy in postmenopausal women and risk of endometrial hyperplasiaHormone replacement therapy for preventing cardiovascular disease in post-menopausal womenOral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushesLong-term hormone therapy for perimenopausal and postmenopausal women.Where is the evidence for effectiveness of treatments for the menopause? Introducing the Cochrane Collaboration.That oestrogen replacement for osteoporosis prevention should no longer be a bone of contentionIs the oral contraceptive or hormone replacement therapy a risk factor for cholelithiasis: A systematic review and meta-analysis.Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.Migraine, menopause and hormonal replacement therapy.Primary prevention of colorectal cancer.Should postmenopausal women be given estrogen?Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis.Role of exogenous and endogenous hormones in endometrial cancer: review of the evidence and research perspectives.Brief report: Coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis.The risks and benefits of long-term estrogen replacement therapyHormone replacement therapy. Protection against the consequences of menopause.Menopausal hormone therapy and venous thromboembolism.Is there a link between oestrogen therapy and gallbladder disease?Estrogen replacement therapy for postmenopausal osteoporosis.Breast cancer and depot-medroxyprogesterone acetate. WHO Collaborative Study of Neoplasia and Steroid Contraceptives.Estrogen replacement therapy (ERT) in high-risk cancer patientsThe association between a functional CYP1A1 polymorphism and colorectal neoplasia risk in post menopausal women.Hormone therapy and cardiovascular risk markers and disease: focus on progestagens.Postmenopausal hormone replacement therapy for primary prevention of cardiovascular and cerebrovascular disease. Recommendation statement from the Canadian Task Force on Preventive Health Care.Have we come full circle - or moved forward? The Women's Health Initiative 10 years on.Menopausal hormone therapy for primary prevention: why the USPSTF is wrong.Oral Contraceptives and HRT Risk of Thrombosis.The menopause: health implications and clinical management.Benefit/risk of estrogen therapy in cardiovascular disease: current knowledge and future challenges.The menopause revisited.Women at cardiac risk: is HRT the route to maintaining cardiovascular health?Hormone replacement therapy again. Risk-benefit relation differs between populations and individuals.Oestrogen supplementation attenuates responses to psychological stress in elderly men rendered hypogonadal after treatment for prostate cancer.Oestrogen and endometrial cancer: a reappraisal.
P2860
Q24187326-3B4C5E9B-9A46-455B-AE59-5AC49F23F2CBQ24201543-B9F5AE7B-8E14-4080-84C0-3DD951E0E91DQ24201974-B318CD5B-3781-4C1E-A22D-FEA000B7D3AFQ24241713-9F2E6512-6D28-48B3-A261-8A88282D0EFFQ24244146-F39517CF-8A12-4FB9-929B-123F52DFDE0BQ24246213-92679EAC-850F-42C1-A2CE-30DA1BF7417DQ30238978-833F4C83-0D6B-4601-9EDC-8E7E962BF259Q31044049-A51A91B3-63C6-45DD-B378-8BF53A56584FQ33565228-AAC1BC86-88CF-4451-A0B4-7635B0982C3EQ33621358-43DB71C5-1F7A-4FC5-966B-49C30BB15127Q33909569-B2656101-2689-4976-906C-2E06DB76CC34Q34039852-C269A3FF-FDFD-47BD-B889-E8264314619AQ34165145-BD64897C-BC4C-4859-81B5-6831D5F52A14Q34192257-65B486E3-8CAD-4346-8533-F1681D1B2955Q34328229-C1566E41-4AC5-412E-8665-5530D7297BD0Q34397284-63D6EED7-67B8-41AC-A806-1C34B1A0150CQ34704488-8BF5EE7B-6551-4C8A-B7A3-C350F111ED59Q35055781-33E730C6-62DD-4C4E-BDAA-16226FF0A8C1Q35852948-CC230DEA-7E4B-43FE-901C-ACE53DE30BCEQ35903637-94DA4725-9903-42C2-B96B-BF7A8E5EEB4AQ36349751-C439829B-AE4A-42B4-A803-11660369A080Q36576202-CB87AC8E-6F62-443C-8511-1DE773870DF7Q36876030-A9DE38D6-84C5-44D5-A173-23780E8DD4F2Q36988226-570B5AF5-BBC4-4ABA-BA25-137A9FFDB39DQ37254723-EC391AA4-6FAA-4897-8E41-3CC60E77D8FEQ37608577-389CE990-0E18-4C33-8D1B-D8E09E80F37CQ37644027-B6162069-BD5D-49FD-B710-F946585C8966Q38011779-F27ECA65-DAD0-4D06-A67F-4BFA35E7CFD4Q38626233-912317A5-C725-49B3-9E56-FE346865EECAQ39066094-4C190F90-8B23-48A7-8CAF-2361D3339C99Q40892229-27210B1C-4546-43E1-A30D-0123510984A0Q40928625-16131D0B-2AA5-4DFB-904F-3E0964D36F4FQ40959293-AF71951F-D92B-4FF3-A498-2D79F550F06FQ41654083-837817FD-2C06-4D49-9383-630D82FC04A8Q42757321-77196CD5-479F-4813-B01C-CDC1BF214A13Q44033173-18DBEC1E-F6E1-4575-9A4E-26E788F1C2DEQ55019215-228DD4C9-39FD-45F9-AA2C-5D7BEBE5181C
P2860
Estrogen replacement therapy II: a prospective study in the relationship to carcinoma and cardiovascular and metabolic problems
description
1979 nî lūn-bûn
@nan
1979 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1979 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
name
Estrogen replacement therapy I ...... ascular and metabolic problems
@ast
Estrogen replacement therapy I ...... ascular and metabolic problems
@en
Estrogen replacement therapy I ...... ascular and metabolic problems
@nl
type
label
Estrogen replacement therapy I ...... ascular and metabolic problems
@ast
Estrogen replacement therapy I ...... ascular and metabolic problems
@en
Estrogen replacement therapy I ...... ascular and metabolic problems
@nl
prefLabel
Estrogen replacement therapy I ...... ascular and metabolic problems
@ast
Estrogen replacement therapy I ...... ascular and metabolic problems
@en
Estrogen replacement therapy I ...... ascular and metabolic problems
@nl
P2093
P1476
Estrogen replacement therapy I ...... ascular and metabolic problems
@en
P2093
E M Beckman
L E Nachtigall
R D Nachtigall
R H Nachtigall
P356
10.1097/00006250-197907000-00017
P407
P577
1979-07-01T00:00:00Z